Tebuconazole (TEB) is a fungicide widely used in vineyards and is a suspected teratogen for humans. The aim of this research was to identify urinary biomarkers and the best sampling time for the biological monitoring of exposure to TEB in agricultural workers. Seven vineyard workers of the Monferrato region, Piedemont, Italy, were investigated for a total of 12 workdays. They treated the vineyards with TEB for 1-2 consecutive days, one of them for 3 days. During each application coveralls, underwears, hand washing liquids and head coverings were used to estimate dermal exposure. For biomonitoring, spot samples of urine from each individual were collected starting from 24 h before the first application, continuing during the application, and again after the application for about 48 h. TEB and its metabolites TEB-OH and TEB-COOH were measured by liquid chromatography/triple quadrupole mass spectrometry. TEB contamination of coveralls and total dermal exposure showed median levels of 6180 and 1020 mg. Urinary TEB-OH was the most abundant metabolite; its excretion rate peaked within 24 h after product application (post 24 h). In this time frame, median levels of TEB-OH and TEB-COOH ranged from 8.0 to 387.8 mg/l and from 5.7 to 102.9 mg/l, respectively, with a ratio between the two metabolites of about 3.5. The total amount of urinary metabolites (U-TEB eq ) post 24 h was significantly correlated with both TEB on coveralls and total dermal exposure (Pearson's r ¼ 0.756 and 0.577). The amount of metabolites excreted in urine represented about 17% of total dermal TEB exposure. Our results suggest that TEB-OH and TEB-COOH in post-exposure urine samples are promising candidates for biomonitoring TEB exposure in agricultural workers.
INTRODUCTION
Tebuconazole (TEB, 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol, CAS number 107534-96-3) is a triazole fungicide used against leaf spot diseases. It acts by inhibiting sterol biosynthesis in fungi (demethylation inhibitor). It was listed among the top 10 active ingredients in the EUfungicides 2003 report 1 and it is used on several crops, especially fruit and vegetables, including grapes; in Italy vineyards cover about 717,000 ha, and are ranked first among the tree crops. 2 From the toxicological point of view, the compound was reviewed by the WHO/FAO Joint Meeting on Pesticide Residues in 1994. 3 The United States Environmental Protection Agency 4 classified TEB as a possible carcinogen, C rating. 5 Because TEB causes malformations at high doses in animals both in vitro and in vivo, 6 the European Food Safety Authority highlighted the possible risk of harm to the unborn child. 7 The general population may be exposed to TEB from ingestion of residues in food and, in rural areas, also through inhalation as bystanders during application on crops or through dermal contact with crops treated with this fungicide. However, higher exposure occurs among agricultural workers during the different work phases of agricultural use: mixing and loading, application, cleaning and maintenance of equipment, and re-entry activities; during these work activities, the skin is the major exposure route. 8, 9 In particular, the respiratory route was found to contribute by only 1.1% of total exposure in vineyard workers applying fungicides in France. 10 Up to now, the biotransformation routes of TEB in humans have not been investigated. In experimental animals (rats, goats and hens) biotransformation involves the consecutive oxidation of a methyl group of the tertiary butyl moiety to yield the alcohol and the carboxylic acid derivatives (4-chlorophenyl)-2,2-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)-1,3-pentanediol (TEB-OH, CAS number 212267-64-6) and 5-(4-chlorophenyl)-2,2-dimethyl-3-(1H-1,2,4-triazol-1ylmethyl)-3-ol-pentanoic acid (TEB-COOH) (for both see Figure 1 ). TEB-OH is then conjugated to yield the glucuronide and sulfate conjugates that are excreted in urine. Unmodified TEB is also excreted in urine, albeit in minor amounts. In rats extensive mineralization takes place through further oxidations with the final formation of 1,2-4-triazole. 3 A simplified biotransformation pathway is shown in Figure 1 .
Biomonitoring is often a valid tool to assess exposure to chemicals, as it allows the measurement of the actual amount of substance absorbed into the body via all sources and routes of exposure, and takes into account the factors that affect the absorption, biotransformation, distribution, and excretion at individual level.
The present study was performed as part of the EU-funded ACROPOLIS (Aggregate and Cumulative Risk of Pesticides: an OnLine Integrated Strategy) research project. 11 The project involved winegrowers who applied TEB in the Monferrato hill vineyards. The aim of the study was to assess exposure to TEB by means of a multilevel approach that consisted of assessing dietary exposure and occupational exposure through a field study in which dermal exposure assessment (Mandic-Rajcevic et al., in preparation) and biological monitoring were performed. To this aim, TEB-OH and TEB-COOH were identified as candidate metabolites and measured, together with TEB, in urine samples of vineyard workers collected before, during and after the application of TEB on grapes. The study confirmed that both TEB-OH and TEB-COOH are biotransformation products of TEB in humans, and made it possible to study the kinetics of their excretion and compare the amount of TEB absorbed through skin with the amount that was biotransformed and excreted in urine.
MATERIALS AND METHODS

Study Subjects
The study involved vineyard workers applying TEB in vineyards and recruited according to the following procedure: the geographic area in Northern Italy where TEB was most sold in the previous season was located; once the Monferrato area in Piedmont was identified, the local health authority was involved so as to get in contact with the vineyard estates eligible for the study; the estates were invited to a meeting during which the study was presented. During the meeting, on a voluntary basis, seven workers volunteered to participate in the study.
The field study was run from May to July 2011. TEB was applied in the vineyards in the form of a diluted oil-in-water emulsion for foliar application on grapes either with a tractor-mounted air blast application or spraying upward with hand-held application equipment. A total of 12 applications were performed.
The research team administered questionnaires, supervised field work and collected information on personal characteristics (age, height, body weight, smoking habits) and occupational information useful to explore determinants and modifiers of exposure. These included the name and brand of the formulation, the concentration of TEB in the formulation, the method of mixing and loading, the size of the treated area, the quantity of formulation applied per area, the application equipment and techniques, any maintenance of the machinery during these activities.
All workers wore cotton coveralls, as specified below; other personal protective equipment such as working boots, gloves and masks, were not supplied and were worn on a discretional basis.
The study was performed in the context of risk evaluation, according to Italian law 81/2008 for health and safety at the work place, under the supervision of an occupational health physician. Each study subject read, understood and signed the specific informed consent form approved by the ethics committee of the University of Milan.
Dermal Exposure
Potential body exposure, defined as the amount of pesticide deposited on work coveralls, and actual dermal exposure, defined as the amount of pesticide deposited on a worker's skin, including body, head and hands, were estimated. In brief, on each application workday the worker wore cotton coveralls (potential body exposure sampler), a cotton t-shirt and a cotton boxer-type underwear (all together actual body exposure samplers). A hospital-type non-woven fabric head cover was worn so as to assess head exposure. Hand exposure was assessed collecting hand washing liquids (100 ml of a 20% v/v mixture of isopropyl alcohol in water, which was poured on the subject's hands and collected in a basin underneath). Total actual exposure was defined as the sum of body plus head plus hand exposures.
Dermal samples were kept at room temperature in a dark place before transport to the laboratory, where they were processed and frozen until analyses that were performed blind, after sample coding. TEB on dermal samplers was determined after desorption by an aqueous/methanol solution in the presence of tebuconazole-D6 as internal standard, by liquid chromatography-triple quadrupole mass spectrometry (LC-MS/MS). More details on methods are described elsewhere (Mandic-Rajcevic et al., in preparation).
Biological Monitoring
Each subject was provided with instructions for urine collection and with a sampling kit consisting of sampling containers and a collection record sheet. The workers were asked to collect samples of each urine starting 24 h before the first day of TEB application, then during TEB application, and continuing for B48 h from the end of the last application. For each urine sample the time of collection was self-recorded. The samples were kept at room temperature and were collected by the research team at the end of each day. Samples were then cooled to 4 1C and delivered to the laboratory for analysis, where they were stored at À 20 1C until analysis, which was performed within 6 months.
Measurement of TEB and its Metabolites
The analysis of dermal samples was performed as described elsewhere (Mandic-Rajcevic et al., in preparation).
For urinary TEB and TEB metabolites the following procedure was adopted. TEB was purchased from Sigma Aldrich (Milano, Italy), TEB-OH and TEB-COOH (purity 97.5% for both) were kindly donated by Bayer Crop Science (Germany). Urine was submitted to enzymatic hydrolysis withglucuronidase (type H-2, Helix Pomatia, Sigma Aldrich) at 37 1C overnight. Urine was purified by on-line turbulent flow chromatography and the analytes were separated and quantified by LC-MS/MS, in the presence of tebuconazole-D6 (TEB-D6, Dr. Ehrenstorfer, LabService, Anzola Emila, Italy) as an internal standard. Turbulent flow chromatography was performed with a TurboFlow system (Thermo Scientific, Rodano, Italy), using a Cyclone column (50 mm length, 2.1 mm internal diameter, Thermo Scientific). Liquid chromatography was performed using a C18 reversed-phase column (Hypersil Gold PFP, 50 mm length, 2.1 mm internal diameter, 5 mm particle size, Thermo Scientific), kept at room temperature, and an isocratic mixture of aqueous acetic acid (0.5%) and acetonitrile (30:70) as eluent, flowing at 0.7 ml/min. Detection and quantification were performed by MS/MS (TSQ Quantum Access, Thermo Scientific) equipped with an electrospray ionization source operating in the positive-ion mode. The ionization source parameters were: spray voltage 4500 V, ion transfer tube temperature 350 1C, vaporization temperature 280 1C, nitrogen as sheath gas and auxiliary gas operating at a pressure of 40 and 10 units (arbitrary scale), tube lens offset 76 V, and skimmer offset À 20 V. Collision-inducted dissociation was performed using Ar, as the collision gas, at a pressure of 1.5 mTorr. The analytes were detected in the positive-ion mode and quantification was based on multiple reaction monitoring following the transitions m/z 308-70 þ 308-125 þ 308-151 (collision energy 27, 28, and 24 eV, Biological monitoring of exposure to TEB Fustinoni et al respectively) for TEB, 324-70 þ 324-151 (collision energy 21 and 29 eV, respectively) for TEB-OH, 338-70 þ 338-163 (collision energy 21 and 24 eV, respectively) for TEB-COOH, and m/z 314-72 þ 314-125 þ 314-154 (collision energy 27, 32, and 25 eV, respectively) for TEB-D6. Retention times were 7.21, 6.42, 6.55, and 7.20 min, respectively, for TEB, TEB-OH, TEB-COOH and TEB-D6. The intra-and inter-day precision of the method, assessed as a percent coefficient of variation, was o10%, accuracy was between 98% and 101%, and the limits of quantification (LOQ, determined according to Miller and Miller 12 ) were 1.5 mg/l for urinary TEB, and 0.3 mg/l for both TEB-OH and TEB-COOH. The throughput was about 50 samples/day.
Urinary creatinine (mg/l) was determined using Jaffe's colorimetric method. 13 
Data Processing and Statistical Analysis
Calculations performed to estimate dermal exposure are described elsewhere (Mandic-Rajcevic et al., in preparation).
Before performing statistical analysis for biomarkers, urine samples were organized according to the timing of urine collection. In particular, the collection time was divided into different time frames:
before the work-shift in which the application took place, called pre-WS; during the work-shift in which the application(s) took place (WS1, WS2 and WS3) first 24 h after the end of the application(s) (post 24 h 1, post 24 h 2, post 24 h 3) from 25 to 48 h after the end of the (last) application (post 25-48 h) any further samples, if present (post 448 h)
The amount of TEB or TEB metabolites in each urine sample collected within each time frame was summed up. Moreover, considering that each time frame had a variable length based on the work duties and the actual times at which different urine samples were collected, TEB-OH amount was normalized for the time frame length to obtain an excretion rate, called TEB-OH rate :
TEBÀOH rate mg=h ð Þ¼ TEBÀOH amount ðmgÞ Time frame length ðhÞ This parameter was used to describe the kinetics of excretion of TEB-OH in urine; analogous calculation was performed for TEB-COOH.
Moreover, the total amount of excreted metabolites was expressed as tebuconazole equivalents U-TEB eq , calculated according to the formula:
where MW TEB , MW TEB-OH , MW TEB-COOH are the molecular weights of the corresponding chemicals. In order to ascertain whether the workers collected all urine samples, as no information on incomplete urine collection was reported, we calculated the expected daily amount of urinary creatinine Creat exp , according to the formula 14 Creat exp mg day
From the ratio between measured and expected daily amount of urinary creatinine the percentage of incomplete urine collection was estimated (results are reported in Table 1 ). This percentage is, however, subject to a large degree of variability and only when it falls outside the range 60-140% should a urine sample be considered unreliable. 15 Finally, the level of TEB eq was adjusted according to the expected excretion of creatinine to obtain a U-TEB eq-crea .
UÀTEB eqÀcrea ðmgÞ ¼
Creat exp mg day
Creat mg day ÂUÀTEB eq ðmgÞ Statistical analysis was performed using SPSS 17.0 for Windows (SPSS, Chicago, IL, USA). Values below the LOQ were assigned a value equal to1/2 LOQ. For the descriptive analysis median, minimum, and maximum values of the distribution were calculated. The variables were transformed into their decimal logarithms and analyzed after verifying that the logarithmic data were normally distributed (Kolmogorov-Smirnov test). Simple linear correlation analysis was used to evaluate the correlation between potential body exposure or actual exposure and urinary biomarkers in the different time frames. Owing to the few data available, WS1 and WS2 (WS), and post 24 h 1, post 24 h 2, post 24 h 3 (post 24 h) data were grouped together and considered as independent observations. A P-valueo0.05 was considered significant.
RESULTS
Study Subjects
A summary of the characteristics of study subjects is given in Table 1 . The median age, height and weight of the seven study workers were 47 years, 180 cm and 90 kg. During the whole period of urine collection, workers excreted a median creatinine amount of 1488 mg/day (from 960 to 2328 mg/day), and this was estimated to be 69% of the expected amount. 14, 15 During the application of TEB in the vineyards, workers prepared the fungicide mixture, filled the tank of the sprayer, either tractormounted or hand-held, sprayed the pesticide, and cleaned the equipment at the end of spraying operations. Three workers worked for 1 day (worker ID 2, 7 and 8), three worked for 2 days (worker ID 3 and 6 for two consecutive days; worker ID 1 for two non-consecutive days, with a break of 6 weeks), and one worked for 3 consecutive days (worker ID 5). The application time ranged from 3 to 10 h; spraying was carried out with an open tractor, hand-held hose (worker ID 3, workday D and worker ID 5 for part of workday H), and closed tractor (worker ID 8); further details on the determinants of exposure are reported elsewhere (MandicRajcevic et al., in preparation). Table 2 reports the excretion rate of TEB-OH and TEB-COOH (TEB-OH rate and TEB-COOH rate , respectively, both in mg/h) for each study subject in each time frame. Missing samples and absence of urine samples in specific time frames are also indicated.
Kinetics of Excretion
TEB-OH was found in pre-WS samples, despite the fact that workers declared absence of exposure. The median pre-WS rate was 1.3 mg/h with a maximum of 2.7 mg/h. During WS1, the median excretion rate increased to 1.8 mg/h, with a maximum of 4.6 mg/h. During post 24 h 1, the median rate was 1.9 mg/h, with a maximum 12.9 mg/h. For the three subjects who performed a second consecutive application, the rate kept on increasing with a median of 7.7 mg/h and a maximum of 9.4 mg/h in WS2, and a median of 10.7 mg/h and a maximum of 11.9 mg/h in post 24 h 2. In post 25-48 h the median excretion rate, 5.8 mg/h, was higher than the excretion rate in post 24 h 1, but lower than in post 24 h 2. In post 448 h the excretion rate, available for three subjects, had a median value of 0.8 mg/h and maximum of 1.1 mg/h. A single worker performed a third consecutive application; for this subject no urine sample in WS3 was available and an excretion rate of 1.1 mg/h in post 24 h 3 was observed. The overall picture showing TEB-OH rate in the different time frames is reported in Figure 2 .
For TEB-COOH rate a very similar pattern was observed, even if excretion rates were one-third lower.
Altogether a wide inter-subject variability was observed, not only in the values of excretion rates, but also in the pattern of excretion. Nevertheless, a clearer picture could be drawn when only the most exposed subjects were considered. In fact, we observed that the overall trend was mostly due to the contribution of two subjects (worker ID 3 and 6) who applied TEB for two consecutive days and presented the highest values of TEB-OH rate (up to 12.9 mg/h). Considering worker ID 3: he applied 99 g of TEB using an open tractor during WS1 (duration 5 h), and he applied 65.7 g of TEB using a hand-held hose during WS2 (duration 6 h). In the case of worker ID 6: he applied 1530 g of TEB using an open tractor during WS1 (duration 10 h), and he applied 900 g of TEB in the same conditions during WS2 (duration 10 h). In both subjects TEB-OH rate increased in the post-exposure periods with maximum values in the post-24 h time frames, and higher values following the second application compared with the first application.
Dermal Exposure and Biomonitoring A summary of results of dermal exposure and urinary biomarkers is reported in Table 3 . The median levels of potential body exposure were 6180, 14,200 and 5520 mg in WS1, WS2 and WS3, respectively; such levels dropped to 188, 420 and 56 mg for actual body exposure, with a median protection factor of 98% provided by the overalls (Mandic-Rajcevic et al., in preparation). Hands accounted for 17% to 86%, whereas the head accounted for 3% to 80% of total actual exposure (712, 1410 and 1170 mg in WS1, WS2 and WS3, respectively).
TEB-OH was the major urinary species, with median levels ranging from 21.1 to 249.0 mg/l, TEB-COOH levels ranged from 7.8 to 51.1 mg/l, and urinary TEB from 2.5 to 4.6 mg/l. For those workers who performed just one application, maximum concentration of both metabolites was reached in post 24 h 1, and for those who performed two consecutive applications was reached in the post 24 h 2. The median ratio between TEB-OH and TEB-COOH was about 3.5. U-TEB eq was calculated to integrate the contribution of both TEB-OH and TEB-COOH and to take into account the different urine volume; in this calculation the contribution of urinary TEB was not considered, as it was small (from 1.3% to 13%) and it was unclear whether or not it could be due, at least in part, to 49  180  100  1608  2400  67  2  B  50  180  95  1488  2280  65  3  C-D  51  178  91  1176  2184  54  5  F-G-H  40  168  57  960  1368  70  6  I-J  41  185  90  2328  2160  108  7  K  47  170  78  1392  1872  74  8  L  36  180  90  2328  2160  108  Minimum  -36  168  57  960  1368  54  Median  -47  180  90  1488  2160  69  Maximum  -51  185  100  2328  2400  108 a Calculated assuming a daily creatinine excretion of 24 mg/kg body weight. Figure 2 . Excretion rate of TEB-OH (mg/h) in studied vineyard workers.
contamination of samples, as testified by the presence of similar levels of TEB in all samples, irrespective of the time frame considered. The volume of urine showed a wide variability within each time frame. Although this can be explained by physiological differences among subjects, variable liquid intake, and different lengths of time, for some subjects, at least, incomplete collection of urine cannot be excluded. Therefore, to take into consideration incomplete urine collection U-TEB eq-crea was also estimated by normalizing the data to the expected creatinine excretion. U-TEB eq-crea was about 30% higher than U-TEB eq , with differences between subjects. Comparing the concentration in the different time frames, the maximum amount of both U-TEB eq and U-TEB eq-crea was found post 24 h. Table 4 shows Pearson's correlation coefficients between dermal exposure and the excretion of U-TEB eq and U-TEB eq-crea in the different time frames. Significant correlations were found between all dermal exposure parameters and both U-TEB eq and U-TEB eq-crea in WS samples (Pearson's r ranging from 0.554 to 0.803), with the exception of head exposure (r ¼ 0.125 and 0.266, P40.05). Significant correlations were also found between most dermal exposure parameters, and both U-TEB eq and U-TEB eq-crea in post-24 h samples (Pearson's r ranging from 0.577 to 0.777), with the exception of hands exposure (r ¼ 0.475 and 0.527, P40.05) and head exposure vs U-TEB eq (r ¼ 0.527, P40.05). No significant correlation was found between dermal exposure parameters post 25-48 h, possibly owing to the low number of available observations (n ¼ 7); the same holds true for post 448 h (n ¼ 3). Correlation coefficients mostly improved using U-TEB eq-crea instead of U-TEB eq .
Correlation between Dermal Exposure and Biomarkers
The correlation between potential body exposure or actual body exposure and U-TEB eq-crea is reported in Figure 3 , both as scatter plot and linear regression with 95% confidence intervals.
DISCUSSION
This study is the first attempt to investigate basic elements for the biological monitoring of exposure to TEB in vineyard workers.
As no data on the metabolism of TEB in humans were previously reported, for the first time in this study TEB-OH and TEB-COOH were measured in vineyard workers' urine. These biotransformation products were found to be the major metabolites both in rats and in goats, even if, in the former, molecules resulting from a more extensive biodegradation were also observed. 3 The excretion kinetics study displayed non-homogeneous behavior among the investigated subjects, showing a wide variability of TEB-OH rate , TEB-COOH rate and trends (Table 2 ). This can be explained by several factors that include: physiological differences between subjects; different exposures, as a result of variable amounts of TEB applied, application methods and times; different tasks; use of personal protective devices and their efficacy; and different compliance with the protocol for urine collection. In this complex picture the overall results are driven by those subjects who had the highest exposures, that is, subjects ID 3 and 6, and who showed similar excretion rates and trends. We considered the data from these subjects as more reliable in comparison with those obtained from subjects with lower exposure; in fact, in the latter, the presence of environmental contamination (as suggested by the pre-WS samples) impacts to a larger extent on low exposures. Moreover, the precision and accuracy associated with measurements close to the quantification limits is lower than in samples with higher concentrations. Therefore, based on the data from subjects ID 3 and 6, a higher excretion of TEB metabolites was observed in the post-24 h time frame, which can be suggested as the best time to collect urine samples for biological monitoring of occupational exposure to TEB in agriculture. This can be done also in spite of the fact that subject ID 3 had a ratio Creat/Creat exp of 0.54 (see Table 1 ), therefore falling outside the range 0.6-1.4 of acceptability for complete urine collection, 15 given the vicinity of the ratio to the lower limit of the acceptable range, and the fact that subject ID 3 Biological monitoring of exposure to TEB Fustinoni et al was considered highly reliable by the study team. However, considering the limit of these results on the kinetics of TEB metabolites, a detailed collection protocol, similar to what is normally available for biomarkers with an established application in occupational health and safety protocols, 16 cannot be specified. Moreover, observing the behavior of these two subjects, who were followed on consecutive days, it appears that the half-life of TEB-OH is much longer than 16 h, roughly corresponding to the time from the end of the previous application and the beginning of the next one; in fact, a progressive increase in the excretion rate was noticed on comparing both WS1 and WS2, and post 24 h 1 and post 24 h 2. The relatively long half-time associated with TEB-OH can be explained considering the relatively high molecular weight of its glucuronide conjugate (MW 499) that, following biliary excretion, undergoes enterohepatic circulation. 3 Furthermore, absorption of pesticides in winegrowers primarily occurs through the skin; 10 this is associated with slow and persisting absorption over time; in fact, following dermal exposure, chemical absorption and distribution are slower than those following inhalation; moreover, dermal absorption may continue even after the end of exposure, when the chemical is not completely removed from skin; these reasons may explain the delayed elimination of urinary metabolites.
Potential body exposure was as high as 21,500 mg, but levels significantly dropped under the coveralls, where actual body exposure was, as median, only 2% of this value (Table 3) . Beside the good protection provided by coveralls, a major role in determining the total actual exposure was played by contamination of the hands; we associated this finding to the use of personal gloves that were most likely contaminated by previous use. Also contamination of the head was significant, but such contribution should be interpreted with caution; in fact, we presumed a lower absorption rate for pesticides coming into contact with the hair than with body skin, as also indicated by the poor correlation between deposits on the head and urinary excretion of metabolites (Table 4 ). Overall, it should be stressed that the use of t-shirts, underwears and head coverings as dermal samplers did not allow measurement of the true dermal exposure, but just an approximation of it; under these conditions total actual exposure overestimates TEB available for dermal absorption.
Levels of TEB-OH and TEB-COOH in urine samples (Table 3) were in the range of tens to hundreds of mg/l; such levels were higher than concentrations of other pesticide metabolites previously reported in the literature for vineyard workers. For example, median ethylenethiourea levels in 13 Italian vineyard workers following the use of ethylenebisdithiocarbamate fungicides was 2.5 mg/g creatinine (from o0.5 to 95.2 mg/g creatinine). 17 Moreover, during the present study, vineyard workers' exposure should be considered mitigated in comparison with the real situation given the use of coveralls and head coverings as dermal samplers; in the absence of such garments a higher internal dose would most likely be measured.
An unexpected result was the presence of TEB metabolites in samples collected in the pre-WS time frame. Possible explanations could be the presence of TEB in the diet, the contamination of the work environment and the use of contaminated gloves. To assess the first issue, duplicate diet samples were collected the day before the application: from preliminary results it can be anticipated that the contribution of TEB in diet was negligible in comparison with the contribution of occupational exposure and cannot justify the levels of TEB metabolite found in the pre-WS time frame. As regards to contamination of the working environment, this was confirmed by wipe samples collected during the workshop and on the machinery the day before application.
The comparison between TEB-OH and TEB-COOH concentrations showed that TEB-OH was the major metabolite, with median levels 3.5-fold higher than those of TEB-COOH (Table 3) ; however, the TEB-COOH to TEB-OH ratio varied among subjects, and in particular, at a higher exposure a lower conversion of the alcohol to carboxylic acid was observed. Such behavior was also similar to that observed in experimental animals. 5 Given its abundance, TEB-OH may be proposed as a representative biomarker of TEB exposure if only one target compound needs to be selected.
To compensate for inter-individual differences in the production of TEB-OH and TEB-COOH (Table 3) , the calculated U-TEB eq was chosen as the best estimate of internal dose; furthermore, the sum of the different amounts of U-TEB eq from WS to post 448 h was regarded as the dose excreted following exposure during the study applications; amounts measured in pre-WS were excluded as negligible and considered as arising from environmental contamination. For each subject the excreted dose was compared with actual dermal exposure; the median urinary excretion rate was estimated to be 16.8% and 21.1% considering U-TEB eq and U-TEB eq-crea , respectively. This excretion rate largely exceeds what was expected based on previous data. In fact, the European Food Safety Authority reported and used for risk assessment of TEB, a dermal absorption rate of 13%, obtained by an in vivo study in monkeys, 7 whereas others reported a skin penetration of 37% when aqueous solutions of TEB were applied to human skin. 5 On the basis of these findings a mean dermal absorption rate of 25% was estimated. After single administration of triazole-labeled TEB to rats, about 70-80% of the dose was excreted in feces and up to 25% in urine. 3 Overall, the expected urinary excretion rate in the vineyard workers in our study should be equal to 6% of dermal exposure as result of the product between dermal absorption and urinary excretion. The threefold difference between expected and measured excretion rate could be related to several factors, including the large degree of approximation in our calculations, differences between experimental animals and humans, and the uncertainties associated with in-field studies.
The statistically significant and good correlations between dermal exposure and U-TEB eq strengthen the value of our findings and support the possibility of using biomonitoring to perform assessment of exposure to TEB (Table 4) . Such possibility offers very interesting prospects, given the difficulty and the high cost of dermal exposure assessment in agriculture. Comparing Pearson's correlation coefficients between the different time frames, the best correlations were found in both WS and post-24 h U-TEB eq ; this is consistent with the association between urinary biomarkers and recent exposure. In post 25-48 h and post 448 h there was no significant correlation, probably owing to the low number of observations in these time frames (n ¼ 7 and 3, respectively). Results obtained using U-TEB eq and U-TEB eq-crea were very similar, with slightly better correlation coefficients for the latter; this may indicate the appropriateness of adjusting U-TEB eq for urinary creatinine to take into account incomplete urine collection.
The major limit of this investigation was the small number of study subjects, which reduces the statistical significance of our observations. Another issue was the artificial lowering of real exposure experienced by the workers studied owing to the use of coveralls and other dermal samplers; as already discussed, the limited exposure tends to obscure the observation of kinetics of TEB metabolites and reduces the generalization of results; similar difficulties were also caused by environmental contamination, which was responsible for the excretion of metabolites even before the application of TEB. Finally, further difficulties can be attributed to different exposure intensities, application methods and schedules that contributed to the wide inter-subject variability. All these issues, once again, highlight the difficulties in carrying out studies in agriculture despite the considerable efforts made to keep all the variability factors under control.
In conclusion our study suggests that biomonitoring may be used to assess exposure to TEB and, in particular, TEB-OH and TEB-COOH in post-exposure urine are promising candidates for biomonitoring TEB exposure in agricultural workers.
